Table of Content

1 Nicotinamide Mononucleotide Supplement Market Overview
1.1 Product Overview and Scope of Nicotinamide Mononucleotide Supplement
1.2 Nicotinamide Mononucleotide Supplement Segment by Type
1.2.1 Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Type (2024-2034)
1.2.2 Powder
1.2.3 Tablets
1.2.4 Solution
1.2.5 Capsules
1.3 Nicotinamide Mononucleotide Supplement Segment by Application
1.3.1 Global Nicotinamide Mononucleotide Supplement Market Value by Application: (2024-2034)
1.3.2 Online Sales
1.3.3 Pharmacy Sales
1.3.4 Supermarket Sales
1.4 Global Nicotinamide Mononucleotide Supplement Market Size Estimates and Forecasts
1.4.1 Global Nicotinamide Mononucleotide Supplement Revenue 2018-2029
1.4.2 Global Nicotinamide Mononucleotide Supplement Sales 2018-2029
1.4.3 Global Nicotinamide Mononucleotide Supplement Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nicotinamide Mononucleotide Supplement Market Competition by Manufacturers
2.1 Global Nicotinamide Mononucleotide Supplement Sales Market Share by Manufacturers (2018-2024)
2.2 Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Nicotinamide Mononucleotide Supplement Average Price by Manufacturers (2018-2024)
2.4 Global Nicotinamide Mononucleotide Supplement Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Product Type & Application
2.7 Nicotinamide Mononucleotide Supplement Market Competitive Situation and Trends
2.7.1 Nicotinamide Mononucleotide Supplement Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nicotinamide Mononucleotide Supplement Players Market Share by Revenue
2.7.3 Global Nicotinamide Mononucleotide Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nicotinamide Mononucleotide Supplement Retrospective Market Scenario by Region
3.1 Global Nicotinamide Mononucleotide Supplement Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nicotinamide Mononucleotide Supplement Global Nicotinamide Mononucleotide Supplement Sales by Region: 2018-2029
3.2.1 Global Nicotinamide Mononucleotide Supplement Sales by Region: 2018-2024
3.2.2 Global Nicotinamide Mononucleotide Supplement Sales by Region: 2024-2029
3.3 Global Nicotinamide Mononucleotide Supplement Global Nicotinamide Mononucleotide Supplement Revenue by Region: 2018-2029
3.3.1 Global Nicotinamide Mononucleotide Supplement Revenue by Region: 2018-2024
3.3.2 Global Nicotinamide Mononucleotide Supplement Revenue by Region: 2024-2029
3.4 North America Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.4.1 North America Nicotinamide Mononucleotide Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nicotinamide Mononucleotide Supplement Sales by Country (2018-2029)
3.4.3 North America Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Mononucleotide Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nicotinamide Mononucleotide Supplement Sales by Country (2018-2029)
3.5.3 Europe Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.6.1 Asia Pacific Nicotinamide Mononucleotide Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nicotinamide Mononucleotide Supplement Sales by Country (2018-2029)
3.6.3 Asia Pacific Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Mononucleotide Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nicotinamide Mononucleotide Supplement Sales by Country (2018-2029)
3.7.3 Latin America Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Mononucleotide Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nicotinamide Mononucleotide Supplement Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Mononucleotide Supplement Sales by Type (2018-2029)
4.1.1 Global Nicotinamide Mononucleotide Supplement Sales by Type (2018-2024)
4.1.2 Global Nicotinamide Mononucleotide Supplement Sales by Type (2024-2029)
4.1.3 Global Nicotinamide Mononucleotide Supplement Sales Market Share by Type (2018-2029)
4.2 Global Nicotinamide Mononucleotide Supplement Revenue by Type (2018-2029)
4.2.1 Global Nicotinamide Mononucleotide Supplement Revenue by Type (2018-2024)
4.2.2 Global Nicotinamide Mononucleotide Supplement Revenue by Type (2024-2029)
4.2.3 Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Type (2018-2029)
4.3 Global Nicotinamide Mononucleotide Supplement Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nicotinamide Mononucleotide Supplement Sales by Application (2018-2029)
5.1.1 Global Nicotinamide Mononucleotide Supplement Sales by Application (2018-2024)
5.1.2 Global Nicotinamide Mononucleotide Supplement Sales by Application (2024-2029)
5.1.3 Global Nicotinamide Mononucleotide Supplement Sales Market Share by Application (2018-2029)
5.2 Global Nicotinamide Mononucleotide Supplement Revenue by Application (2018-2029)
5.2.1 Global Nicotinamide Mononucleotide Supplement Revenue by Application (2018-2024)
5.2.2 Global Nicotinamide Mononucleotide Supplement Revenue by Application (2024-2029)
5.2.3 Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application (2018-2029)
5.3 Global Nicotinamide Mononucleotide Supplement Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Double Wood Supplements
6.1.1 Double Wood Supplements Corporation Information
6.1.2 Double Wood Supplements Description and Business Overview
6.1.3 Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Double Wood Supplements Nicotinamide Mononucleotide Supplement Product Portfolio
6.1.5 Double Wood Supplements Recent Developments/Updates
6.2 Quicksilver Scientific
6.2.1 Quicksilver Scientific Corporation Information
6.2.2 Quicksilver Scientific Description and Business Overview
6.2.3 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product Portfolio
6.2.5 Quicksilver Scientific Recent Developments/Updates
6.3 California Gold Nutrition
6.3.1 California Gold Nutrition Corporation Information
6.3.2 California Gold Nutrition Description and Business Overview
6.3.3 California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.3.4 California Gold Nutrition Nicotinamide Mononucleotide Supplement Product Portfolio
6.3.5 California Gold Nutrition Recent Developments/Updates
6.4 ProHealth Longevity
6.4.1 ProHealth Longevity Corporation Information
6.4.2 ProHealth Longevity Description and Business Overview
6.4.3 ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.4.4 ProHealth Longevity Nicotinamide Mononucleotide Supplement Product Portfolio
6.4.5 ProHealth Longevity Recent Developments/Updates
6.5 Renue by Science
6.5.1 Renue by Science Corporation Information
6.5.2 Renue by Science Description and Business Overview
6.5.3 Renue by Science Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Renue by Science Nicotinamide Mononucleotide Supplement Product Portfolio
6.5.5 Renue by Science Recent Developments/Updates
6.6 Do Not Age
6.6.1 Do Not Age Corporation Information
6.6.2 Do Not Age Description and Business Overview
6.6.3 Do Not Age Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Do Not Age Nicotinamide Mononucleotide Supplement Product Portfolio
6.6.5 Do Not Age Recent Developments/Updates
6.7 Nutriop
6.6.1 Nutriop Corporation Information
6.6.2 Nutriop Description and Business Overview
6.6.3 Nutriop Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Nutriop Nicotinamide Mononucleotide Supplement Product Portfolio
6.7.5 Nutriop Recent Developments/Updates
6.8 AFEGA Anti-Aging-Shop
6.8.1 AFEGA Anti-Aging-Shop Corporation Information
6.8.2 AFEGA Anti-Aging-Shop Description and Business Overview
6.8.3 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.8.4 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product Portfolio
6.8.5 AFEGA Anti-Aging-Shop Recent Developments/Updates
6.9 Borealis
6.9.1 Borealis Corporation Information
6.9.2 Borealis Description and Business Overview
6.9.3 Borealis Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Borealis Nicotinamide Mononucleotide Supplement Product Portfolio
6.9.5 Borealis Recent Developments/Updates
6.10 MAAC10 Formulas
6.10.1 MAAC10 Formulas Corporation Information
6.10.2 MAAC10 Formulas Description and Business Overview
6.10.3 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.10.4 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product Portfolio
6.10.5 MAAC10 Formulas Recent Developments/Updates
6.11 Xi'an Angel Biotechnology Co., Ltd.
6.11.1 Xi'an Angel Biotechnology Co., Ltd. Corporation Information
6.11.2 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Description and Business Overview
6.11.3 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product Portfolio
6.11.5 Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
6.12 Longevity Box
6.12.1 Longevity Box Corporation Information
6.12.2 Longevity Box Nicotinamide Mononucleotide Supplement Description and Business Overview
6.12.3 Longevity Box Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Longevity Box Nicotinamide Mononucleotide Supplement Product Portfolio
6.12.5 Longevity Box Recent Developments/Updates
6.13 Age Science
6.13.1 Age Science Corporation Information
6.13.2 Age Science Nicotinamide Mononucleotide Supplement Description and Business Overview
6.13.3 Age Science Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Age Science Nicotinamide Mononucleotide Supplement Product Portfolio
6.13.5 Age Science Recent Developments/Updates
6.14 Nutravita
6.14.1 Nutravita Corporation Information
6.14.2 Nutravita Nicotinamide Mononucleotide Supplement Description and Business Overview
6.14.3 Nutravita Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Nutravita Nicotinamide Mononucleotide Supplement Product Portfolio
6.14.5 Nutravita Recent Developments/Updates
6.15 Hebei Paihang Import And Export Co., Ltd.
6.15.1 Hebei Paihang Import And Export Co., Ltd. Corporation Information
6.15.2 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Description and Business Overview
6.15.3 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product Portfolio
6.15.5 Hebei Paihang Import And Export Co., Ltd. Recent Developments/Updates
6.16 Aeternum
6.16.1 Aeternum Corporation Information
6.16.2 Aeternum Nicotinamide Mononucleotide Supplement Description and Business Overview
6.16.3 Aeternum Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Aeternum Nicotinamide Mononucleotide Supplement Product Portfolio
6.16.5 Aeternum Recent Developments/Updates
6.17 Toniiq
6.17.1 Toniiq Corporation Information
6.17.2 Toniiq Nicotinamide Mononucleotide Supplement Description and Business Overview
6.17.3 Toniiq Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Toniiq Nicotinamide Mononucleotide Supplement Product Portfolio
6.17.5 Toniiq Recent Developments/Updates
6.18 ProNutrition
6.18.1 ProNutrition Corporation Information
6.18.2 ProNutrition Nicotinamide Mononucleotide Supplement Description and Business Overview
6.18.3 ProNutrition Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.18.4 ProNutrition Nicotinamide Mononucleotide Supplement Product Portfolio
6.18.5 ProNutrition Recent Developments/Updates
6.19 Genex Formulas
6.19.1 Genex Formulas Corporation Information
6.19.2 Genex Formulas Nicotinamide Mononucleotide Supplement Description and Business Overview
6.19.3 Genex Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Genex Formulas Nicotinamide Mononucleotide Supplement Product Portfolio
6.19.5 Genex Formulas Recent Developments/Updates
6.20 Physicians Longevity
6.20.1 Physicians Longevity Corporation Information
6.20.2 Physicians Longevity Nicotinamide Mononucleotide Supplement Description and Business Overview
6.20.3 Physicians Longevity Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Physicians Longevity Nicotinamide Mononucleotide Supplement Product Portfolio
6.20.5 Physicians Longevity Recent Developments/Updates
6.21 AlphaFit
6.21.1 AlphaFit Corporation Information
6.21.2 AlphaFit Nicotinamide Mononucleotide Supplement Description and Business Overview
6.21.3 AlphaFit Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.21.4 AlphaFit Nicotinamide Mononucleotide Supplement Product Portfolio
6.21.5 AlphaFit Recent Developments/Updates
6.22 Mega NMN
6.22.1 Mega NMN Corporation Information
6.22.2 Mega NMN Nicotinamide Mononucleotide Supplement Description and Business Overview
6.22.3 Mega NMN Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Mega NMN Nicotinamide Mononucleotide Supplement Product Portfolio
6.22.5 Mega NMN Recent Developments/Updates
6.23 Lovita Foods
6.23.1 Lovita Foods Corporation Information
6.23.2 Lovita Foods Nicotinamide Mononucleotide Supplement Description and Business Overview
6.23.3 Lovita Foods Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Lovita Foods Nicotinamide Mononucleotide Supplement Product Portfolio
6.23.5 Lovita Foods Recent Developments/Updates
6.24 Jarrow Formulas
6.24.1 Jarrow Formulas Corporation Information
6.24.2 Jarrow Formulas Nicotinamide Mononucleotide Supplement Description and Business Overview
6.24.3 Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Jarrow Formulas Nicotinamide Mononucleotide Supplement Product Portfolio
6.24.5 Jarrow Formulas Recent Developments/Updates
6.25 Body Union
6.25.1 Body Union Corporation Information
6.25.2 Body Union Nicotinamide Mononucleotide Supplement Description and Business Overview
6.25.3 Body Union Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.25.4 Body Union Nicotinamide Mononucleotide Supplement Product Portfolio
6.25.5 Body Union Recent Developments/Updates
6.26 Peak Performance
6.26.1 Peak Performance Corporation Information
6.26.2 Peak Performance Nicotinamide Mononucleotide Supplement Description and Business Overview
6.26.3 Peak Performance Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2018-2024)
6.26.4 Peak Performance Nicotinamide Mononucleotide Supplement Product Portfolio
6.26.5 Peak Performance Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Mononucleotide Supplement Industry Chain Analysis
7.2 Nicotinamide Mononucleotide Supplement Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Mononucleotide Supplement Production Mode & Process
7.4 Nicotinamide Mononucleotide Supplement Sales and Marketing
7.4.1 Nicotinamide Mononucleotide Supplement Sales Channels
7.4.2 Nicotinamide Mononucleotide Supplement Distributors
7.5 Nicotinamide Mononucleotide Supplement Customers
8 Nicotinamide Mononucleotide Supplement Market Dynamics
8.1 Nicotinamide Mononucleotide Supplement Industry Trends
8.2 Nicotinamide Mononucleotide Supplement Market Drivers
8.3 Nicotinamide Mononucleotide Supplement Market Challenges
8.4 Nicotinamide Mononucleotide Supplement Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Nicotinamide Mononucleotide Supplement Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nicotinamide Mononucleotide Supplement Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Nicotinamide Mononucleotide Supplement Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Nicotinamide Mononucleotide Supplement Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Nicotinamide Mononucleotide Supplement, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Product Type & Application
Table 12. Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nicotinamide Mononucleotide Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide Supplement as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nicotinamide Mononucleotide Supplement Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nicotinamide Mononucleotide Supplement Sales by Region (2018-2024) & (K Units)
Table 18. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Region (2018-2024)
Table 19. Global Nicotinamide Mononucleotide Supplement Sales by Region (2024-2029) & (K Units)
Table 20. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Region (2024-2029)
Table 21. Global Nicotinamide Mononucleotide Supplement Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Region (2018-2024)
Table 23. Global Nicotinamide Mononucleotide Supplement Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Region (2024-2029)
Table 25. North America Nicotinamide Mononucleotide Supplement Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nicotinamide Mononucleotide Supplement Sales by Country (2018-2024) & (K Units)
Table 27. North America Nicotinamide Mononucleotide Supplement Sales by Country (2024-2029) & (K Units)
Table 28. North America Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Nicotinamide Mononucleotide Supplement Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nicotinamide Mononucleotide Supplement Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nicotinamide Mononucleotide Supplement Sales by Country (2018-2024) & (K Units)
Table 32. Europe Nicotinamide Mononucleotide Supplement Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Nicotinamide Mononucleotide Supplement Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nicotinamide Mononucleotide Supplement Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nicotinamide Mononucleotide Supplement Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Nicotinamide Mononucleotide Supplement Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nicotinamide Mononucleotide Supplement Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Nicotinamide Mononucleotide Supplement Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nicotinamide Mononucleotide Supplement Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nicotinamide Mononucleotide Supplement Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Nicotinamide Mononucleotide Supplement Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Nicotinamide Mononucleotide Supplement Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nicotinamide Mononucleotide Supplement Sales (K Units) by Type (2018-2024)
Table 51. Global Nicotinamide Mononucleotide Supplement Sales (K Units) by Type (2024-2029)
Table 52. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Type (2018-2024)
Table 53. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Type (2024-2029)
Table 54. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Type (2018-2024)
Table 57. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Type (2024-2029)
Table 58. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Type (2018-2024)
Table 59. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Type (2024-2029)
Table 60. Global Nicotinamide Mononucleotide Supplement Sales (K Units) by Application (2018-2024)
Table 61. Global Nicotinamide Mononucleotide Supplement Sales (K Units) by Application (2024-2029)
Table 62. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Application (2018-2024)
Table 63. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Application (2024-2029)
Table 64. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application (2018-2024)
Table 67. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application (2024-2029)
Table 68. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Application (2018-2024)
Table 69. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Application (2024-2029)
Table 70. Double Wood Supplements Corporation Information
Table 71. Double Wood Supplements Description and Business Overview
Table 72. Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Double Wood Supplements Nicotinamide Mononucleotide Supplement Product
Table 74. Double Wood Supplements Recent Developments/Updates
Table 75. Quicksilver Scientific Corporation Information
Table 76. Quicksilver Scientific Description and Business Overview
Table 77. Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product
Table 79. Quicksilver Scientific Recent Developments/Updates
Table 80. California Gold Nutrition Corporation Information
Table 81. California Gold Nutrition Description and Business Overview
Table 82. California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. California Gold Nutrition Nicotinamide Mononucleotide Supplement Product
Table 84. California Gold Nutrition Recent Developments/Updates
Table 85. ProHealth Longevity Corporation Information
Table 86. ProHealth Longevity Description and Business Overview
Table 87. ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. ProHealth Longevity Nicotinamide Mononucleotide Supplement Product
Table 89. ProHealth Longevity Recent Developments/Updates
Table 90. Renue by Science Corporation Information
Table 91. Renue by Science Description and Business Overview
Table 92. Renue by Science Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Renue by Science Nicotinamide Mononucleotide Supplement Product
Table 94. Renue by Science Recent Developments/Updates
Table 95. Do Not Age Corporation Information
Table 96. Do Not Age Description and Business Overview
Table 97. Do Not Age Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Do Not Age Nicotinamide Mononucleotide Supplement Product
Table 99. Do Not Age Recent Developments/Updates
Table 100. Nutriop Corporation Information
Table 101. Nutriop Description and Business Overview
Table 102. Nutriop Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Nutriop Nicotinamide Mononucleotide Supplement Product
Table 104. Nutriop Recent Developments/Updates
Table 105. AFEGA Anti-Aging-Shop Corporation Information
Table 106. AFEGA Anti-Aging-Shop Description and Business Overview
Table 107. AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product
Table 109. AFEGA Anti-Aging-Shop Recent Developments/Updates
Table 110. Borealis Corporation Information
Table 111. Borealis Description and Business Overview
Table 112. Borealis Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Borealis Nicotinamide Mononucleotide Supplement Product
Table 114. Borealis Recent Developments/Updates
Table 115. MAAC10 Formulas Corporation Information
Table 116. MAAC10 Formulas Description and Business Overview
Table 117. MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product
Table 119. MAAC10 Formulas Recent Developments/Updates
Table 120. Xi'an Angel Biotechnology Co., Ltd. Corporation Information
Table 121. Xi'an Angel Biotechnology Co., Ltd. Description and Business Overview
Table 122. Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product
Table 124. Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
Table 125. Longevity Box Corporation Information
Table 126. Longevity Box Description and Business Overview
Table 127. Longevity Box Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Longevity Box Nicotinamide Mononucleotide Supplement Product
Table 129. Longevity Box Recent Developments/Updates
Table 130. Age Science Corporation Information
Table 131. Age Science Description and Business Overview
Table 132. Age Science Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Age Science Nicotinamide Mononucleotide Supplement Product
Table 134. Age Science Recent Developments/Updates
Table 135. Nutravita Corporation Information
Table 136. Nutravita Description and Business Overview
Table 137. Nutravita Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Nutravita Nicotinamide Mononucleotide Supplement Product
Table 139. Nutravita Recent Developments/Updates
Table 140. Hebei Paihang Import And Export Co., Ltd. Corporation Information
Table 141. Hebei Paihang Import And Export Co., Ltd. Description and Business Overview
Table 142. Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product
Table 144. Hebei Paihang Import And Export Co., Ltd. Recent Developments/Updates
Table 145. Aeternum Corporation Information
Table 146. Aeternum Description and Business Overview
Table 147. Aeternum Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Aeternum Nicotinamide Mononucleotide Supplement Product
Table 149. Aeternum Recent Developments/Updates
Table 150. Toniiq Corporation Information
Table 151. Toniiq Description and Business Overview
Table 152. Toniiq Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Toniiq Nicotinamide Mononucleotide Supplement Product
Table 154. Toniiq Recent Developments/Updates
Table 155. ProNutrition Corporation Information
Table 156. ProNutrition Description and Business Overview
Table 157. ProNutrition Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. ProNutrition Nicotinamide Mononucleotide Supplement Product
Table 159. ProNutrition Recent Developments/Updates
Table 160. Genex Formulas Corporation Information
Table 161. Genex Formulas Description and Business Overview
Table 162. Genex Formulas Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Genex Formulas Nicotinamide Mononucleotide Supplement Product
Table 164. Genex Formulas Recent Developments/Updates
Table 165. Physicians Longevity Corporation Information
Table 166. Physicians Longevity Description and Business Overview
Table 167. Physicians Longevity Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Physicians Longevity Nicotinamide Mononucleotide Supplement Product
Table 169. Physicians Longevity Recent Developments/Updates
Table 170. AlphaFit Corporation Information
Table 171. AlphaFit Description and Business Overview
Table 172. AlphaFit Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. AlphaFit Nicotinamide Mononucleotide Supplement Product
Table 174. AlphaFit Recent Developments/Updates
Table 175. Mega NMN Corporation Information
Table 176. Mega NMN Description and Business Overview
Table 177. Mega NMN Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Mega NMN Nicotinamide Mononucleotide Supplement Product
Table 179. Mega NMN Recent Developments/Updates
Table 180. Lovita Foods Corporation Information
Table 181. Lovita Foods Description and Business Overview
Table 182. Lovita Foods Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Lovita Foods Nicotinamide Mononucleotide Supplement Product
Table 184. Lovita Foods Recent Developments/Updates
Table 185. Jarrow Formulas Corporation Information
Table 186. Jarrow Formulas Description and Business Overview
Table 187. Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Jarrow Formulas Nicotinamide Mononucleotide Supplement Product
Table 189. Jarrow Formulas Recent Developments/Updates
Table 190. Body Union Corporation Information
Table 191. Body Union Description and Business Overview
Table 192. Body Union Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Body Union Nicotinamide Mononucleotide Supplement Product
Table 194. Body Union Recent Developments/Updates
Table 195. Peak Performance Corporation Information
Table 196. Peak Performance Description and Business Overview
Table 197. Peak Performance Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 198. Peak Performance Nicotinamide Mononucleotide Supplement Product
Table 199. Peak Performance Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Nicotinamide Mononucleotide Supplement Distributors List
Table 203. Nicotinamide Mononucleotide Supplement Customers List
Table 204. Nicotinamide Mononucleotide Supplement Market Trends
Table 205. Nicotinamide Mononucleotide Supplement Market Drivers
Table 206. Nicotinamide Mononucleotide Supplement Market Challenges
Table 207. Nicotinamide Mononucleotide Supplement Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nicotinamide Mononucleotide Supplement
Figure 2. Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Nicotinamide Mononucleotide Supplement Market Share by Type in 2022 & 2029
Figure 4. Powder Product Picture
Figure 5. Tablets Product Picture
Figure 6. Solution Product Picture
Figure 7. Capsules Product Picture
Figure 8. Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Nicotinamide Mononucleotide Supplement Market Share by Application in 2022 & 2029
Figure 10. Online Sales
Figure 11. Pharmacy Sales
Figure 12. Supermarket Sales
Figure 13. Global Nicotinamide Mononucleotide Supplement Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Nicotinamide Mononucleotide Supplement Market Size (2018-2029) & (US$ Million)
Figure 15. Global Nicotinamide Mononucleotide Supplement Sales (2018-2029) & (K Units)
Figure 16. Global Nicotinamide Mononucleotide Supplement Average Price (US$/Unit) & (2018-2029)
Figure 17. Nicotinamide Mononucleotide Supplement Report Years Considered
Figure 18. Nicotinamide Mononucleotide Supplement Sales Share by Manufacturers in 2022
Figure 19. Global Nicotinamide Mononucleotide Supplement Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Nicotinamide Mononucleotide Supplement Players: Market Share by Revenue in 2022
Figure 21. Nicotinamide Mononucleotide Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Nicotinamide Mononucleotide Supplement Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Nicotinamide Mononucleotide Supplement Sales Market Share by Country (2018-2029)
Figure 24. North America Nicotinamide Mononucleotide Supplement Revenue Market Share by Country (2018-2029)
Figure 25. United States Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Nicotinamide Mononucleotide Supplement Sales Market Share by Country (2018-2029)
Figure 28. Europe Nicotinamide Mononucleotide Supplement Revenue Market Share by Country (2018-2029)
Figure 29. Germany Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Nicotinamide Mononucleotide Supplement Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Nicotinamide Mononucleotide Supplement Revenue Market Share by Region (2018-2029)
Figure 36. China Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Nicotinamide Mononucleotide Supplement Sales Market Share by Country (2018-2029)
Figure 46. Latin America Nicotinamide Mononucleotide Supplement Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Nicotinamide Mononucleotide Supplement by Type (2018-2029)
Figure 56. Global Revenue Market Share of Nicotinamide Mononucleotide Supplement by Type (2018-2029)
Figure 57. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Nicotinamide Mononucleotide Supplement by Application (2018-2029)
Figure 59. Global Revenue Market Share of Nicotinamide Mononucleotide Supplement by Application (2018-2029)
Figure 60. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Application (2018-2029)
Figure 61. Nicotinamide Mononucleotide Supplement Value Chain
Figure 62. Nicotinamide Mononucleotide Supplement Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed